coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Swinton PCN, Salford (LAD) · Health Inequalities Profile

    PCN U57786 · NHS Greater Manchester Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    47,726

    Registered population

    60.3% aged 18–64

    19.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    24.3%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~11,363

    Core20 residents (est.)

    Resident basis; registered basis ~11,728 · see page 3

    8,358

    Hypertension register

    +10.94% in 3 yrs · England +5.60%

    463

    SMI register

    12.5% of Salford (LAD)'s

    1,129

    COPD register

    Reviews +0.49% in 3 yrs

    Forecast to 2030

    10,395

    Hypertension patients, 2030

    +2,037 on today

    72.7%

    QRISK ≥20% on statins, 2030

    +3.01pp over 3 yrs

    5.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    61.7%
    Asthma annual reviews trail Salford and England.

    Coverage is 61.7% against 71.6% in Salford and 65.7% in England (1,147 scale gap across 2,997 patients), which may reflect unverified recall differences.

    -11.0%
    Heart failure reviews declined over three years.

    Annual reviews fell 11.0% over 2023 to 2025 (England +8.7%) to 74.1% (England 78.5%), which could reflect recall or template coding differences.

    75.8%
    Blood pressure and frail diabetes control lead England.

    Hypertension treatment to target reaches 75.8% (England 70.3%) and frail diabetes HbA1c control reaches 90.6% (England 81.9%), showing strong clinical management once reviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 19.1% of the list, exceeding Salford and England

    Swinton PCN serves 47,726 registered patients. Patients aged 65+ make up 19.1% (9,105), above Salford (LAD) (14.4%), NHS Greater Manchester Integrated Care Board (14.9%), and England (17.9%). Working-age adults (18-64) comprise 60.3% (28,795), below Salford (LAD) (64.8%), the ICB (63.3%), and England (62.7%), while children (0-17) represent 20.6% (9,826) (Salford 21.4%, ICB 21.8%, England 19.6%). Roma residents represent 0.1% (Salford 0.2%, ICB 0.1%, England 0.2%) and Gypsy or Irish Traveller residents 0.0% (0.1% across comparators). Age data reflect registered patients, whereas ethnicity uses resident Census estimates.

    Age profile

    0–1720.6%
    18–6460.3%
    65+19.1%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Salford (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Salford LA)2,9802,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)90.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.0%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Salford LA)1,5101,0219552024/25
    Falls deaths, all ages, per 100,000 (Salford LA)15.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation averages 24.3% across the PCN but spans 47.3 pp between practices

    Swinton PCN’s Core20 share is 24.3%, below Salford (LAD) (44.0%) and NHS Greater Manchester ICB (40.7%), but above England (21.0%). Practice concentration spans 47.3 pp, from 1.32% at The Sides Medical Practice to 48.63% (5,948 estimated patients) at Silverdale Medical Practice, with The Lakes Medical Practice at 29.0% (2,891) and The Poplars Medical Practice at 23.71% (2,703). Practice estimates sum to 11,728 against the 11,363 resident estimate, a difference consistent with differing population bases. Outreach should focus on Silverdale Medical Practice where Core20 concentration and volume coincide.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Silverdale48.6% · 5,948 patients
    Lakes Medical29.0% · 2,891 patients
    Poplars Medical23.7% · 2,703 patients
    Sides Medical1.3% · 186 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    463

    SMI register

    0.96% recorded prevalence

    303

    Learning disability register

    0.63% recorded prevalence

    10

    Care homes, 359 beds

    In the PCN catchment

    9.2%

    Provide unpaid care

    Salford (LAD), Census 2021

    The PCN records 303 learning disability patients (0.6%, vs Salford 0.5%, ICB 0.6%, England 0.6%) and 463 severe mental illness patients (1.0%, vs Salford 1.1%, ICB 1.1%, England 1.0%), alongside 10 catchment care homes with 359 beds. With learning disability matching England and severe mental illness in line with national levels, sustaining annual reviews alongside care-home liaison may be the primary workload to protect.

    Severe mental illness: physical health checks

    SMI blood pressure checks reach 82.6% (England 83.4%), spanning 77.9% at Silverdale Medical Practice to 81.7% at The Sides Medical Practice. BMI recording is 85.6% (England 82.1%) and alcohol recording is 83.7% (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,358

    Hypertension register

    +10.94%

    Register growth, 3 yrs

    Salford (LAD) +5.45% · England +5.60%

    +4.38pp

    BP control, under 80

    ≤140/90 · +5.18pp aged 80+

    +2,037

    More patients by 2030

    Forecast 10,395 (21.36%)

    Hypertension case-finding and control

    Hypertension prevalence is 17.4% (8,358 patients), above Salford (12.4%), the ICB (14.4%), and England (15.2%), growing +10.9% over 2023 to 2025 (England +5.6%). Treatment to target reaches 75.8% (England 70.3%; Salford 77.6%), and recent blood pressure readings reach 92.3% (England 90.0%). However, annual heart failure reviews including functional capacity assessment cover 74.1% of the 609 patients on the register (1.3% prevalence), lagging England (78.5%), the ICB (80.0%), and Salford (80.7%) after changing by -11.0% over 2023 to 2025 while England rose +8.7%. Strong blood pressure control sits alongside falling heart failure reviews, so prioritising recall for annual functional assessments across the 609 heart failure patients is the immediate clinical priority.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 66.3% (England 63.6%; ICB 67.0%), though three-year growth (+4.8%) trails England (+6.2%). Among patients aged 65+, lipid-regulating prescribing is 10,661 per 1,000, below Salford (14,002) and England (18,056). Prescribing in older patients sits below Salford and England benchmarks, pointing to an opportunity to audit lipid therapy.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202697,068£1.60£1.94£1.86£155,309
    Cardiovascular (all), 2025135,733£2.76£3.15£3.33£374,623

    In 2026, the PCN prescribed 97,068 items for lipid-regulating drugs at £1.60 per item (England £1.86; ICB £1.94; Salford £1.54). Across these items, spend was £25,238 less than at England's unit cost. Lower unit cost than England means the PCN spends less per item, offering headroom to expand lipid-regulating coverage without exceeding benchmark spend.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +9.43%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.22%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual reviews reach 61.7% across the 2,997-patient register, trailing England (65.7%) and Salford (71.6%), representing an unreviewed scale gap of 1,147 patients. Review rates span from 49.9% at The Poplars Medical Practice to 81.4% at The Sides Medical Practice. COPD reviews also trail at 71.7% (England 76.4%). Meanwhile, youth asthma prescribing reaches 1,970 items per 1,000 (England 1,488), youth second-hand smoke recording lags at 74.9% (England 78.8%), and smoking cessation offers fell 4.8 pp over 2023 to 2025 to 91.8% (England +0.1 pp).

    Cancer register and children's immunisation

    The cancer register comprises 2,026 patients (4.2% prevalence, above England's 3.8% and Salford's 2.9%). In childhood immunisations, Swinton PCN exceeds national benchmarks at age 5 with 94.2% for first-dose MMR and 90.8% for second-dose MMR, showing a 3.4 pp dose difference. Pre-school 4-in-1 booster coverage reaches 81.7%, sitting 13.3 pp below the 95.0% target despite exceeding England (80.9%) and the ICB (80.5%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.5%

    England 91.0%

    6-in-1 complete primary course at 24 months92.3%

    England 92.2%

    MMR dose 1 at 24 months88.9%

    England 88.3%

    MMR dose 2 at age 590.8%

    England 82.8%

    4-in-1 pre-school booster at age 581.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, NHS Greater Manchester ICB recorded 55.6% of cancers diagnosed at stage 1 or 2 among cases with a known stage (70.8%), sitting below the 75.0% national ambition by 19.4 pp (2,268.2 extra cases to reach 75.0%). System stage data is not PCN-specific. Swinton PCN's cancer register stands at 4.2% (2,026 patients). Breast screening coverage is 75.1% (England 69.9%), though Silverdale Medical Practice records 68.4%. Cervical screening for women aged 25-49 is 71.2% (England 66.8%), ranging from 67.0% at The Lakes Medical Practice to 78.4% at The Sides Medical Practice. Sustaining screening uptake across practices supports early detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For July 2026 (provisional), Northern Care Alliance NHS Foundation Trust achieved 78.6% on the 62-day referral to treatment standard, below the 85.0% target by 6.4 pp, though above the ICB (75.7%) and England (71.2%). Its 28-day faster diagnosis standard was 75.2% (target 75.0%), trailing England's 79.3%. On 31-day combined treatment, it reached 94.5% against the 96.0% standard. Diagnostic waits show pressure in endoscopy: 40.0% waited 6+ weeks for colonoscopy, 39.9% for flexi sigmoidoscopy, and 36.5% for gastroscopy, while 15.7% waited 6+ weeks across all diagnostic tests. Endoscopy delays at the acute provider could slow lower-gastrointestinal diagnostic pathways.

    Pathways within standard (%)Northern Care AllianceManchesterBoltonGreater Manchester ICBEngland
    28-day faster diagnosis (75%)75.2080.0680.4879.5379.32
    31-day treatment (96%)94.5492.5496.5096.4992.50
    62-day referral to treatment (85%)78.6572.8569.6675.7371.16
    Diagnostic waits over 6 weeks (%)Northern Care AllianceManchesterBoltonEngland
    MRI5.0911.682.0521.40
    CT4.1014.6619.409.92
    Echocardiography31.484.913.4828.48
    Colonoscopy40.044.511.3330.83
    Gastroscopy36.4829.352.0629.02
    All 15 DM01 tests15.718.9815.7823.14
    Community services activitySalford residentsGreater Manchester ICB
    Care contacts37,955573,310
    Referrals3,34094,470
    Patients with a contact15,440183,535

    Community services (residents of Salford), Jun 2026 (provisional). For June 2026 (provisional), adults aged 65+ accounted for 53.9% of borough residents' community service contacts (20,470 of 37,955). In Swinton PCN, registered patients aged 65+ make up 19.1% of the list (9,105 patients). Provider-specific community activity is not captured, but the borough volume demonstrates substantial service demand concentrated in older residents. A heavy community caseload among older people requires coordinated intermediate and primary care management.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Clinical QOF achievement reaches up to 100.0% despite an 18.7 pp phone access spread

    Overall QOF achievement spans 90.7% at Silverdale Medical Practice to 97.6% at The Sides Medical Practice (England 92.5%). Clinical achievement reaches 99.2% at The Lakes Medical Practice to 100.0% at The Sides Medical Practice (England 97.1%). Vaccination achievement spans 59.6 pp, from 18.9% at Silverdale Medical Practice to 78.5% at The Sides Medical Practice (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Lakes Medical11029.059.9%84.7%88.0%
    Silverdale11948.663.7%78.3%87.5%
    Sides Medical1071.350.9%66.9%83.9%
    Poplars Medical10623.745.1%81.5%83.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSalford (LAD)AssetPCNSalford (LAD)
    Care homes (catchment)10 (359 beds)n/aSchools (catchment)68n/a
    Children's centres316Places of worship21118
    Libraries316Primary schools (LA maintained)1452
    Primary academies721

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma annual reviews cover 61.7% of the 2,997 register (Salford 71.6%, ICB 66.2%, England 65.7%), spanning 49.9% at The Poplars Medical Practice to 81.4% at The Sides Medical Practice (1,147 scale gap). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Heart failure and COPD review recall

    Reviews trail England for heart failure (74.1% of 609 vs 78.5%, down 11.0% over 2023 to 2025 vs England +8.7%) and COPD (71.7% of 1,129 vs 76.4%, +0.5% vs +2.8%), while smoking cessation offers fell 4.8 pp to 91.8% (England 94.2%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Dementia register and care-home review

    Recorded dementia prevalence is 0.6% (274 patients across 47,726 registered), below ICB (0.7%) and England (0.8%) and matching Salford (0.6%), giving an unadjusted benchmark gap of +23 to +99 despite 19.1% (9,105) aged 65+. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Heart failure functional review recall (p5)Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)—PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical and breast screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Heart failure and COPD review recall (p12)COPD register · COPD patients with a review in the last 12 months · Patients with COPD who had a review in the last 12 months (denominator incl. PCAs)Core20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 3 · Dementia register and care-home review (p12)Registered population · Aged 65+ · Count of Registered Patients aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15